Почетна › Бубрежен карцином (Реналноклеточен карцином) › Мисури › St. Louis
Клинички испитувања за Бубрежен карцином (Реналноклеточен карцином) во St. Louis, MO
23 студии за Бубрежен карцином (Реналноклеточен карцином) бараат учесници на локации во и околу St. Louis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Washington University Medicine, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Се регрутираФаза 1
- Washington University School of Medicine, St Louis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и уште 4
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Се регрутираФаза 1/2
- Washington University in St. Louis, St Louis
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и уште 5
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Се регрутираФаза 1/2
- Washington University, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Се регрутираНабљудувачка студија
- Washington University, St Louis
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Се регрутираФаза 3
- Washington University School of Medicine ( Site 0114), St Louis
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Се регрутираФаза 1/2
- Washington University School of Medicine, St Louis
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
Се регрутираФаза 2
- Washington University School of Medicine, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Се регрутираФаза 1/2
- Washington University, St Louis
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Се регрутираФаза 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · на 16 милји
- и уште 1
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Се регрутираФаза 1/2
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- и уште 5
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Се регрутираФаза 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и уште 6
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Research Site, St Louis
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Се регрутираФаза 1
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Се регрутираФаза 1
- Washington University School of Medicine, St Louis
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Се регрутираФаза 3
- Missouri Baptist Medical Center, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Се регрутираФаза 1
- Washington University School of Medicine, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Се регрутираФаза 2
- Siteman Cancer Center, Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Се регрутираФаза 1
- Washington University Medical Campus, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Се регрутираФаза 1/2
- Washington University, St Louis
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Се регрутираФаза 3
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и уште 4
Испитувања за Бубрежен карцином (Реналноклеточен карцином) во други градови
- Houston, TX35 студии
- New York City, NY27 студии
- Nashville, TN23 студии
- Dallas, TX23 студии
- Los Angeles, CA20 студии
- Boston, MA16 студии
- Baldwin Park, CA16 студии
- Philadelphia, PA15 студии
- Pittsburgh, PA15 студии
- Queens, NY15 студии
- Rochester, MN14 студии
- Cleveland, OH14 студии
Други студии во St. Louis
- Рак на бели дробови со не-мали клетки73 студии
- Рак на дојка64 студии
- Метастатски карцином54 студии
- Колоректален карцином50 студии
- Рак (сите типови)46 студии
- Рак на простата46 студии
- Рак на бели дробови39 студии
- Карцином на јајниците38 студии
- Карцином на панкреасот33 студии
- Рак на ендометриумот29 студии
- Сквамозноклеточен карцином на глава и врат28 студии
- Срцева слабост26 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.